Idiopathic pulmonary fibrosis (IPF)

New Drug To Treat a Desperate Disease

Author
- Dr. Gifford Jones  Sunday, January 20, 2013
| Print friendly | Email Us

Several months ago I wrote about a tennis partner who was slowly dying of idiopathic pulmonary fibrosis (IPF). We both knew there was no cure for this disease. Nor could I foresee any help for many years. I was wrong on that point. But I was right about my message of hope.

I always tell seriously ill patients the story of the man sentenced to death by the King. Because the King was a lover of horses, the man received a reprieve by promising he’d teach the King’s horse to fly within one year. His friends laughed at him, but he explained, “Within a year the King may die, I may die or the horse may die. Besides, within a year the horse may learn to fly.” The last thing to lose is hope.

Patients with IPF face a grim future. The average length of life from the time of diagnosis of IPF is usually two to five years. Fortunately, fate is occasionally kind, as some patients have lived as long as 20 years.

In some cases the course of the disease remains fairly stable. This was the case of my tennis friend. But then it became apparent that the disease was beginning to progress. During tennis games he developed a dry hacking cough, chest discomfort, but even more ominous, progressive shortness of breath along with weakness and fatigue.

IPF is associated with extensive, progressive, scarring of lung tissue. The alveoli (air sacs) in lungs begin to stiffen and become thick, decreasing the amount of oxygen in the blood stream. In effect, IPF is a slow strangulation of the body’s vital oxygen supply.

During final days any physical activity becomes an extreme effort. As my friend remarked, “It requires hours to do anything. It’s like being trapped under water and trying to surface for air.” It’s easy to understand how doctors treating these cases feel frustrated as there’s little to offer in treatment.

Sir William Olser, one of this country’s greatest physicians, felt this way when a colleague asked how he treated another difficult problem, emphysema. Osler replied, “I send these patients to Egypt”. His startled colleague asked,”Is it for the climate?” “No” Osler replied, “It’s the farthest place I can think of to send them.” It was Osler’s way of saying he had no treatment to offer them.

I had no idea when I wrote about IPF several months ago that in this short interval I’d have good news for some IPF patients. A new medication called. “Esbriet” (pirfenidone) is now available in Germany, France, Sweden, Austria, Denmark, Norway, Iceland, 27 countries in the European Union, and has just been approved by Health Canada.

Dr. Charles Chan, Professor of Medicine and Respirologist at the University of Toronto, once shared Osler’s frustration. But now he’s says “After a decade of failed clinical trials of multiple innovative drugs for IPF, Esbriet is an exciting one for IPF patients. Finally we have a treatment option with proven benefit for patients with this challenging disease.”

Esbriet is designed to fight a two-pronged attack on the underlying problems of idiopathic pulmonary fibrosis, namely the inflammation and tough scarring that eventually choke and kill lung tissue.

Esbriet accomplishes this task by decreasing the formation of cells called fibroblasts that are responsible for triggering scarring and fibrosis of air sacs in the lungs. In addition, Esbriet has an anti-inflammatory effect which helps to slow down the progression of the disease and thereby preserves exercise tolerance.

The usual dose is one oral tablet three times a day. Fortunately, Esbriet is well tolerated by most patients. A few complain of nausea, fatigue, diarrhea and heartburn.

Even if Esbriet had been available several months ago it would not have helped my friend as his IPF was too advanced at that time. But Esbriet can help to decrease the progression of those who suffer from the mild to moderate form of IPF. This is a huge step in the right direction to fight this challenging disease. And Osler would be pleased to know Egypt need no longer be an option.

Disqus Comments

W. Gifford-Jones M.D is the pen name of Dr. Ken Walker graduate of Harvard. Dr. Walker’s website is: docgiff.com.

Dr. Walker can be reached at: .(JavaScript must be enabled to view this email address).

.






Most Shared CFP stories



What's New On CFP:

  1. Latest American News
    By News on the Net -- --News Headlines
  2. Our Crucial Choice of the War on Terror
    By Daniel Greenfield -- --Crime-Terror-Security
  3. Obama: If a congressional vote says executive amnesty is illegal, ‘I will veto that vote’
    By Dan Calabrese -- --American Politics
  4. Statement by the Prime Minister of Canada on the murder of Russian politician Boris Nemtsov
    By News on the Net -- --Canada
  5. Obama’s True Enemy
    By Douglas V. Gibbs -- --Cover Story
  6. Latest News on Ebola and Infectious Diseases
    By News on the Net -- --News Headlines
  7. Jihadi John: Another rich terrorist who didn’t need a job
    By Jeff Crouere -- --Cover Story
  8. Obama’s Little Shop of Horrors!
    By Leigh Bravo -- --Cover Story
  9. Latest World News
    By News on the Net -- --News Headlines
  10. First Day at CPAC 2015
    By Dr. Ileana Johnson Paugh -- --Cover Story
  11. Equatorial Glaciers?—Yeah!
    By Dr. Klaus L.E. Kaiser -- --Global Warming-Energy-Environment
  12. Lexus RC 350 ‘F-spires’ to sportiness
    By Jim Bray -- --Automotive News and Reviews
  13. Ford gives its innovative F-150 an icy reception in Quebec
    By Jim Bray -- --Automotive News and Reviews
  14. Obama’s own former intel chief: John Kerry ‘out of touch with reality’ on terrorism
    By Robert Laurie -- --American Politics
  15. Scott Walker Casts Himself as Champion of ‘Hard-Working Taxpayers’
    By Heritage Foundation -- --American Politics
  16. I know how things are, but here’s why you should be encouraged
    By Herman Cain -- --American Life, History, Education
  17. Lois Lerner emails are now the subject of a criminal investigation
    By Robert Laurie -- --American Politics
  18. Latest News on Religion
    By News on the Net -- --News Headlines
  19. #WelcomeBibi—Iran sneaks nuclear facility; Netanyahu must address Congress
    By A. Dru Kristenev -- --American Politics
  20. Latest News On ISIS and Radical Islam
    By News on the Net -- --News Headlines
  21. Government Takeover of the Internet Begins
    By Arnold Ahlert -- --Cover Story
  22. A Letter to the Senate
    By Alan Joel -- --Cover Story
  23. Obama’s Self-Professed “Confusion” About Islamic Terror
    By Raymond Ibrahim -- --Cover Story
  24. Conservatives and “Gaffes”
    By Bruce Walker -- --Cover Story
  25. The Emperor Knows He Has No Clothes
    By Diane Weber Bederman -- --American Politics
  26. Twelve Takeaways From America’s Biggest Conservative Conference
    By Heritage Foundation -- --American Politics
  27. Twenty Reasons To Be Cheerful On International Polar Bear Day 2015
    By Guest Column -- --Global Warming-Energy-Environment
  28. Obama Trolls for Help on Illegal Immigration: Courts Jeb Bush!
    By John Lillpop -- --American Politics
  29. Ted Cruz at CPAC: ‘Demand Action, Not Talk’ From Candidates
    By News on the Net -- --Video
  30. Video: Ben Shapiro: First the Came for the Jews
    By News on the Net -- --American Politics









Caruba: Professional Writing Services



Pursuant to Title 17 U.S.C. 107, other copyrighted work is provided for educational purposes, research, critical comment, or debate without profit or payment. If you wish to use copyrighted material from this site for your own purposes beyond the 'fair use' exception, you must obtain permission from the copyright owner.

Views are those of authors and not necessarily those of Canada Free Press. Content is Copyright 1997-2014 the individual authors.

Site Copyright 1997-2014 Canada Free Press.Com Privacy Statement


Powered by ExpressionEngine